snake venom antiserum bul bio inj.sol 100au/amp
equine antivenom immunoglobulin - inj.sol (ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ) - 100au/amp - equine antivenom immunoglobulin 100au - immunosera and immunoglobulins
viperfav inj.co.inf
sanofi pasteur s.a., lyon, france 2, avenue pont pasteur, 69348 lyon cedex 07 - equine antivenom immunoglobulin - inj.co.inf (ΠΥΚΝΟ ΔΙΑΛΥΜΑ ΓΙΑ ΠΑΡΑΣΚΕΥΗ ΔΙΑΛΥΜΑΤΟΣ ΓΙΑ ΕΝΔΟΦΛΕΒΙΑ ΕΓΧΥΣΗ) - equine antivenom immunoglobulin 0mg - immune sera
jayempi
nova laboratories ireland limited - azathioprine - Απόρριψη μοσχεύματος - Ανοσοκατασταλτικά - jayempi is indicated in combination with other immunosuppressive agents for the prophylaxis of transplant rejection in patients receiving allogenic kidney, liver, heart, lung or pancreas transplants. azathioprine is indicated in immunosuppressive regimens as an adjunct to immunosuppressive agents that form the mainstay of treatment (basis immunosuppression). jayempi is used as an immunosuppressant antimetabolite either alone or, more commonly, in combination with other agents (usually corticosteroids) and/ or procedures which influence the immune response. jayempi is indicated in patients who are intolerant to glucocorticosteroids or if the therapeutic response is inadequate despite treatment with high doses of glucocorticosteroids, in the following diseases:severe active rheumatoid arthritis (chronic polyarthritis) that cannot be kept under control by less toxic agents (disease-modifying anti-rheumatic -medicinal products – dmards)auto-immune hepatitis systemic lupus erythematosusdermatomyositispolyarteritis nodosapemphigus vulgaris and bullous pemphigoidbehçet’s diseaserefractory auto-immune haemolytic anaemia, caused by warm igg antibodieschronic refractory idiopathic thrombocytopenic purpurajayempi is used for the treatment of moderately severe to severe forms of chronic inflammatory bowel disease (ibd) (crohn’s disease or ulcerative colitis) in patients in whom glucocorticosteroid therapy is necessary, but where glucocorticosteroids are not tolerated, or in whom the disease is untreatable with other common means of first choice. it is also indicated in adult patients in relapsing multiple sclerosis, if an immunomodulatory therapy is indicated but beta interferon therapy is not possible, or a stable course has been achieved with previous treatment with azathioprine. 3jayempi is indicated for the treatment of generalised myasthenia gravis. depending on the severity of the disease, jayempi should be given in combination with glucocorticosteroids because of slow onset of action at the beginning of treatment and the glucocorticosteroid dose should be gradually reduced after several months of treatment.
fluenz
medimmune llc - reassortant του ιού της γρίπης (ζωντανό εξασθενημένο) από τα ακόλουθα στελέχη:a/california/7/2009 (h1n1)pdm09 σαν στέλεχος, a/victoria/361/2011 (h3n2) σαν στέλεχος, b/massachusetts/2/2012 σαν στέλεχος - influenza, human; immunization - Εμβόλια - Προφύλαξη της γρίπης σε άτομα 24 μηνών έως και 18 ετών. Η χρήση του fluenz θα πρέπει να βασίζεται στις επίσημες συστάσεις.
pandemic influenza vaccine h5n1 astrazeneca (previously pandemic influenza vaccine h5n1 medimmune)
astrazeneca ab - ανασυνδυασμένος ιός της γρίπης (ζωντανός εξασθενημένος) του ακόλουθου στελέχους: στέλεχος a / vietnam / 1203/2004 (h5n1) - Γρίπη, Ανθρώπινα - Εμβόλια - Προφύλαξη από τη γρίπη σε επίσημα δηλωθείσα πανδημία σε παιδιά και εφήβους ηλικίας από 12 μηνών έως 18 ετών. Εμβόλιο πανδημικής γρίπης h5n1 astrazeneca πρέπει να χρησιμοποιείται σύμφωνα με τις επίσημες οδηγίες.
nimbex 2mg/ml solution for injection or infusion
aspen pharma trading limited (0000009582) 3016 lake drive, citywest business campus, dublin 24, d24 x586 - cisatracurium besilate - solution for injection or infusion - 2mg/ml - cisatracurium besilate (8000001647) 2,68mg - cisatracurium
tracrium 10mg/ml injection
aspen pharma trading limited (0000009582) 3016 lake drive, citywest business campus, dublin 24, d24 x586 - atracurium besilate - injection - 10mg/ml - atracurium besilate (0064228815) 10mg - atracurium
i.s.m. immune globulin human/καζουρησ 16%(0.32g/2mlamp) inj.sol
ΚΑΖΟΥΡΗΣ ΑΝΤΩΝΙΟΣ - immunoglobulin human normal - ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ - 16%(0.32g/2mlamp) - ΑΝΟΣΟΣ ΟΡΟΣ
ivhebex 5000 iu/vial κονισ και διαλυτησ για διαλυμα προσ εγχυση
ΒΙΑΝΕΞ Α.Ε. ΑΝΩΝΥΜΟΣ ΕΜΠΟΡΟΒΙΟΜΗΧΑΝΙΚΗ-ΤΟΥΡΙΣΤΙΚΗ-ΞΕΝΟΔΟΧΕΙΑΚΗ ΚΑΙ ΝΑΥΤΙΛΙΑΚΗ ΑΝΩΝΥΜΟΣ ΕΤΑΙΡΕΙΑ Δ.Τ. ΒΙΑΝΕΞ Α.Ε. (0000010313) Οδ - hepatitis b immunoglobulin human - ΚΟΝΙΣ ΚΑΙ ΔΙΑΛΥΤΗΣ ΓΙΑ ΔΙΑΛΥΜΑ ΠΡΟΣ ΕΓΧΥΣΗ - 5000 iu/vial - 8000043972 hepatitis b immunoglobulin human 5000.000000 iu - hepatitis b immunoglobulin
hepacaf ps.sol.inf 5000iu/vial
ΙΦΕΤ ΑΕ 18ο χλμ. Λεωφ. Μαραθώνος,, 153 51 153 51, Παλλήνη Αττικής 210.6603400-6603522 - hepatitis b immunoglobulin human - ps.sol.inf (ΚΟΝΙΣ ΚΑΙ ΔΙΑΛΥΤΗΣ ΓΙΑ ΔΙΑΛΥΜΑ ΠΡΟΣ ΕΓΧΥΣΗ) - 5000iu/vial - hepatitis b immunoglobulin human - hepatitis b immunoglobulin